cefuroxime has been researched along with Psoriasis in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walecka, I | 1 |
Olszewska, M | 1 |
Rakowska, A | 1 |
Slowinska, M | 1 |
Sicinska, J | 1 |
Piekarczyk, E | 1 |
Kowalska-Oledzka, E | 1 |
Goralska, B | 1 |
Rudnicka, L | 1 |
1 other study available for cefuroxime and Psoriasis
Article | Year |
---|---|
Improvement of psoriasis after antibiotic therapy with cefuroxime axetil.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Dose-Response Relationship, Drug; Female; Humans; Ma | 2009 |